ReviewCancer communications (London, England)2021

Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges.

Shu-Jin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.